Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of polysubstance use on the health-related quality of life among people who inject drugs undergoing opioid agonist treatment following treatment for hepatitis c virus.
Gormley MA, Zhang W, Self S, Ewing JA, Heo M, Roth P, Pericot-Valverde I, Rennert L, Akiyama MJ, Norton BL, Litwin AH. Gormley MA, et al. Among authors: pericot valverde i. J Subst Use. 2024;29(5):836-842. doi: 10.1080/14659891.2023.2254391. Epub 2023 Sep 6. J Subst Use. 2024. PMID: 39502837
Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study.
Lopes SS, Heo M, Pericot-Valverde I, Norton BL, Taylor LE, Tsui JI, Mehta SH, Feinberg J, Kim AY, Lum PJ, Page K, Murray-Krezan C, Anderson J, Litwin AH, The Hero Study Group. Lopes SS, et al. Among authors: pericot valverde i. Viruses. 2024 Sep 30;16(10):1551. doi: 10.3390/v16101551. Viruses. 2024. PMID: 39459883 Free PMC article. Clinical Trial.
Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO Study.
Litwin AH, Tsui JI, Heo M, Mehta SH, Taylor LE, Lum PJ, Feinberg J, Kim AY, Norton BL, Pericot-Valverde I, Arnsten J, Meissner P, Karasz A, McKee MD, Ward JW, Johnson N, Agyemang L, Stein ES, Thomas A, Borsuk C, Blalock KL, Wilkinson S, Wagner K, Carty J, Murray-Krezan C, Anderson J, Jacobsohn V, Luetkemeyer AF, Falade-Nwulia O, Groome M, Davies S, Costello K, Page K; HERO Study Group. Litwin AH, et al. Among authors: pericot valverde i. JAMA Netw Open. 2024 Aug 1;7(8):e2430024. doi: 10.1001/jamanetworkopen.2024.30024. JAMA Netw Open. 2024. PMID: 39186268 Free article. Clinical Trial.
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cure.
Lopes SS, Pericot-Valverde I, Dotherow JE, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Karasz A, Arnsten J, Moschella P, Heo M, Litwin AH; HERO study group. Lopes SS, et al. Among authors: pericot valverde i. Drug Alcohol Depend. 2024 Sep 1;262:111384. doi: 10.1016/j.drugalcdep.2024.111384. Epub 2024 Jul 6. Drug Alcohol Depend. 2024. PMID: 38991632
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study.
Lopes SS, Pericot-Valverde I, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Karasz A, Arnsten J, Moschella P, Heo M, Litwin AH. Lopes SS, et al. Among authors: pericot valverde i. BMC Infect Dis. 2024 Feb 23;24(1):251. doi: 10.1186/s12879-024-09124-3. BMC Infect Dis. 2024. PMID: 38395747 Free PMC article.
Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study.
Heo M, Norton BL, Pericot-Valverde I, Mehta SH, Tsui JI, Taylor LE, Lum PJ, Feinberg J, Kim AY, Arnsten JH, Sprecht-Walsh S, Page K, Murray-Krezan C, Anderson J, Litwin AH; HERO Study Group. Heo M, et al. Among authors: pericot valverde i. J Hepatol. 2024 May;80(5):702-713. doi: 10.1016/j.jhep.2023.12.020. Epub 2024 Jan 17. J Hepatol. 2024. PMID: 38242324
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study.
Lopes SS, Pericot-Valverde I, Arnsten J, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Moschella P, Heo M, Litwin AH. Lopes SS, et al. Among authors: pericot valverde i. Int J Drug Policy. 2024 Jan;123:104288. doi: 10.1016/j.drugpo.2023.104288. Epub 2023 Dec 15. Int J Drug Policy. 2024. PMID: 38103458 Clinical Trial.
63 results